PVCT
Price:
$0.062
Market Cap:
$26.06M
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology firm dedicated to pioneering immunotherapy treatments. These therapies are grounded in its proprietary halogenated xanthene platform. Among its key developments is PV-10, an experimental autolytic cancer immunotherapy. This treatment is being explored for a range of adult solid tumor malignancies, encompassing melanoma and various gastrointestinal cancers (such as hepatocellular carcinoma, metastatic colorectal cancer to the liver, metastatic neuroendocrine tumors to the liver, and metastatic uveal melanoma to the liver). It also targets pediatric solid tumors, including neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and o...[Read more]
Industry
Biotechnology
IPO Date
1997-01-15
Stock Exchange
OTC
Ticker
PVCT
According to Provectus Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Provectus Biopharmaceuticals, Inc. over the last ten years is 4.37%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), PVCT's Dividend Yield was at its highest in in the December 2016 quarter at 45.88%. The Dividend Yield was at its lowest in in the June 2016 quarter at 0%.
Average
4.37%
Median
0%
Minimum
0%
Maximum
43.74%
Discovering the peaks and valleys of Provectus Biopharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 43.74%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | -100.00% |
| 2016 | 43.74% | Infinity% |
The current Dividend Yield of Provectus Biopharmaceuticals, Inc. (PVCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
4.37%
Provectus Biopharmaceuticals, Inc.’s Dividend Yield is less than Defence Therapeutics Inc. (0%), less than Sernova Corp. (0%), less than MedMira Inc. (0%), less than Cynata Therapeutics Limited (0%), less than Starpharma Holdings Limited (0%), less than Bonus BioGroup Ltd. (0%), less than WOWI, Inc. (0%), less than Celyad Oncology S.A. (0%), less than Microbix Biosystems Inc. (0%), less than Next Science Limited (100.00%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $20.00M | |
| 0% | $39.76M | |
| 0% | $34.17M | |
| 0% | $54.17M | |
| 0% | $206.25M | |
| 0% | $151.83M | |
| 0% | $6.76K | |
| 0% | $11.19M | |
| 0% | $30.11M | |
| 100.00% | $292.63K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Provectus Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Provectus Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Provectus Biopharmaceuticals, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Provectus Biopharmaceuticals, Inc. (PVCT)?
What is the highest Dividend Yield for Provectus Biopharmaceuticals, Inc. (PVCT)?
What is the 3-year average Dividend Yield for Provectus Biopharmaceuticals, Inc. (PVCT)?
What is the 5-year average Dividend Yield for Provectus Biopharmaceuticals, Inc. (PVCT)?
How does the current Dividend Yield for Provectus Biopharmaceuticals, Inc. (PVCT) compare to its historical average?